The potential importance of these interactions extends further, with the possibility of the formation of protein-complex adducts that either retain their cytotoxic activity against tumor cells or result in cytotoxic adducts per se, taking advantage of a possible passive targeting effect of albumin and transferrin. The gene discussed is TF; the disease is neoplasm.